Skip to main content
. 2019 Jan 15;9(1):e022776. doi: 10.1136/bmjopen-2018-022776

Table 3.

Biological and diagnosis tests of patients with confirmed AHF syndrome

All patients with AHF
(n=507)
Group 1
(n=335)
Group 2
(n=172)
P value
Biological analysis
 Performed 507 (100%) 335 (100%) 172 (100%)
 Sodium, mmol/L 138 (135; 141) 138 (135; 141) 139 (135; 141) 0.40
 Potassium, mmol/L 4 (4, 5) 4 (4, 5) 4 (4, 5) 0.89
 Creatinine clearance, mL/min 50 (35; 69.05) 40 (29; 49.9) 78.5 (67; 91) <0.01
 Creatinine clearance <30 mL/min 89 (17.55%) 89 (26.57%) 0 (0%) <0.01
 Haemoglobin, g/L 130 (110, 140) 120 (110, 130) 130 (130, 140) 0.06
 Troponin positive 271 (53.45%) 195 (58.21%) 76 (44.19%) <0.01
 BNP, ng/L 991 (507.5; 2443.5) 1157.5 (569.25; 2680.5) 534 (291; 1292) <0.01
 Pro-BNP, ng/L 4025 (1729; 8863) 5120 (2520; 12 399.75) 2513 (1146.5; 5376.5) <0.01
ECG
 Performed 500 (98.61%) 329 (98.20%) 171 (99.41%)
 Sinusal 220 (44%) 145 (43.28%) 75 (43.6%) 0.92
 Atrial fibrillation 213 (42.01) 139 (41.49%) 74 (43.02%) 1.00
 Driven 44 (8.8%) 33 (9.85%) 11 (6.4%) 0.19
 AVB 21 (4.14%) 14 (4.18%) 7 (4.07%) 0.86
 LBBB 86 (17.2%) 64 (19.1%) 22 (12.79%) <0.05
 RBBB 59 (11.8%) 34 (10.15%) 25 (14.53%) 0.43
 Repolarisation disorder 101 (20.2%) 73 (21.79%) 28 (16.28%) 0.09
Chest X-ray
 Performed 481 (94.87%) 318 (94.92%) 163 (94.76%)
 Normal 24 (4.73%) 11 (3.28%) 13 (7.56%) 0.20
 Cardiomegaly 235 (48.86%) 171 (51.04%) 64 (37.21%) 0.01
 Interstitial opacities 284 (59.04%) 202 (60.3%) 82 (47.67%) 0.02
 Alveolar opacities 108 (22.45%) 64 (19.1%) 44 (25.58%) 0.05

Data are median (IQR) mmol/L, median (IQR) mL/min, median (IQR) g/dL, median (IQR) ng/L or number (%) of patients.

Group 1: patients with CRS; group 2: patients with normal renal function.

AHF, acute heart failure; AVB, atrioventricular block; BNP, brain natriuretic peptide; CRS, cardiorenal syndrome; LBBB, left bundle branch block; RBBB, right bundle branch block.